首页> 外文OA文献 >ACTR-45. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)

【2h】

ACTR-45. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)

机译：ACTR-45。在新诊断出血栓多子（TMZ）和放射疗法（RTZ）的1阶段1，多中心，开放标签研究，在新诊断为血栓血糖级（Glioblastoma，NDGBM）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Daniela Bota; Warren Mason; Santosh Kesari; David Piccioni; Dawit Aregawi; Annick Desjardins; Benjamin Winograd; Steven D Reich; Nancy Levin; Mohit Trikha;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study [J] . H.Athanassiou, M.Synodinou, E.Maragoudakis, European Journal of Cancer Supplements . 2003,第5期

机译：311替莫唑胺（TMZ）联合放疗（RT）与单独放疗（RT）在新诊断的多形性胶质母细胞瘤（GBM）中的应用：一项随机III期研究
2. EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma. [J] . Brandes AA, Stupp R, Hau European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010,第2期

机译：EORTC研究26041-22041：在新诊断的胶质母细胞瘤中，伴有替莫唑胺（TMZ）和放疗（PTK）与PTK787 / ZK222584（PTK / ZK）进行的I / II期研究。
3. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial [J] . Burri Stuart H., Prabhu Roshan S., Sumrall Ashley L., Journal of neuro-oncology. . 2015,第2期

机译：在新近诊断的高级别神经胶质瘤患者术后，立即在肿瘤切除术后立即使用替莫唑胺（TMZ）放置BCNU晶片，然后进行TMZ放疗：一项前瞻性，多机构，II期试验的最终结果
4. ACTR-45. A PHASE 1 MULTICENTER OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA ndGBM) [O] . Daniela Bota, Warren Mason, Santosh Kesari, 2017

机译：ACTR-45。在新诊断的WHO IV级恶性胶质瘤（胶质母细胞瘤ndGBM）中对马立佐米（MRZ）与替莫唑胺（TMZ）和放疗（RT）进行的第一阶段多中心开放式研究
5. ACTR-71. FULL ENROLLMENT RESULTS FROM THE PHASE 1/2, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) ± BEVACIZUMAB (BEV) IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, RGBM) [O] . Daniela Bota, Annick Desjardins, Warren Mason, 2017

机译：ACTR-71。 IV级恶性胶质瘤（Glioblastoma，RGBM）中的阶段1/2，Marizomib（MRZ）±Bevacizumab（BEV）的阶段1/2，多中心，开放标签研究的全部注册结果

ACTR-45. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)

著录项

引文网络

相似文献

相关主题

期刊订阅